Navigation Links
MD Anderson, MedImmune join forces to advance cancer immunotherapy
Date:3/13/2014

will provide MedImmune with an invaluable opportunity to evaluate the biological impact of our immune-mediated cancer agents, both as monotherapy and combination therapy."

"Our partnership with MedImmune will provide us with exciting agents to study in novel pre-surgical clinical trials aimed at identifying early clinical signals and mechanistic insights, which will drive future immunotherapy strategies for the benefit of patients," said platform Scientific Director Padmanee Sharma, M.D., Ph.D., associate professor of Genitourinary Medical Oncology at MD Anderson.

The agreement is the third of a limited number of immunotherapy collaborations to be reached by MD Anderson with leading-edge industry partners.

"MedImmune has deep expertise in cancer immunotherapy reflected in its powerful drug pipeline," said Ferran Prat, Ph.D., J.D., MD Anderson vice president of strategic industry ventures. "This agreement opens up new possibilities for MD Anderson and MedImmune."

"We have a select group of immunotherapy partners and will soon stop accepting new agreements in order to ensure that we can fully deliver for our existing partners," Prat said.

Allison's basic science research on T cell biology led to an entirely new method of treating cancer called immune checkpoint blockade, which blocks receptors on the surface of T cells that tumors use to turn off immune attack.

Allison created an antibody to the checkpoint CTLA-4 and worked in its development as the drug ipilimumab (Yervoy), the first drug of its kind and also the first to be approved by the U.S. Food and Drug Administration for late-stage melanoma. More than 20 percent of melanoma patients given the drug develop long-lasting remissions for five years and longer.

Since immune checkpoint blockade treats the immune system, rather than the tumor directly, it will have application to other cancer types as well. "The era of immune system therapies for cancer is rea
'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Sleep Apnea Treatment Becoming More Popular in New York After Long Island Dental Sleep Medicine Begins Treatment on OJ Anderson, Giants Super Bowl Champion
2. Dr. James Sanderson, Jr. Of SanDentistry in Hoover, Alabama Joins the TeethWhiteningforFree.com Family
3. UT MD Anderson, GlaxoSmithKline to collaborate on new approach to cancer immune therapy
4. New research reinforces danger of drinking alcohol while pregnant
5. Forces of Nature’s Skin Tags Control is World’s Only Organic Skin Tags Removal Treatment
6. Ten Years of Advancing Excellence in African Healthcare: Pfizer and Accordia Join Forces to Improve Health Services for Underserved Populations
7. Age Spots Beauty Balm from Forces of Nature Offers Safe, Organic Option for Age Spot Removal
8. Heart Attack Reinforces Farmers’ Market Manager’s Mission and Alliance with HMHP
9. TELUS and Esprida Join Forces to Offer Wireless Machine-to-Machine Remote Management Solutions for Business
10. Scalp Dermatitis Control by Forces of Nature Offers Brand-New OTC Organic Solution for Common Scalp Condition
11. St. Vincent Hospital and Lakeview Health Join Forces Against Rising Jacksonville Addiction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2015)... ... August 02, 2015 , ... ... muscles and connective tissues of a woman’s pelvic organs (uterus, bladder, and ... straining, heavy lifting, obesity, constipation, multiple vaginal deliveries, genetics, smoking, and the ...
(Date:8/1/2015)... ... 2015 , ... AlignLife Office Coordinator Heather Pugh earned the position ... patients at this natural health care center in Winamac. , "Oftentimes patients are in ... role is vital to our approach because we want to focus on the patient ...
(Date:8/1/2015)... ... 2015 , ... Western University of Health Sciences’ newest class ... growing percentage of U.S. physicians, and reflects the diversity of the communities where ... message delivered by John W. Becher, DO, president of the American Osteopathic Association, ...
(Date:8/1/2015)... (PRWEB) , ... August 01, 2015 , ... The condition ... among both men and women often causing pain and discomfort. Those who spend a ... circulatory problem, and Northeast Houston Vein Center is doing what it can to create ...
(Date:8/1/2015)... ... August 01, 2015 , ... Tina Wilcoxson, owner of Freeport ... was given that honor by the National Retail Federation, the largest retail trade association ... one of three Maine business owners to be named as such. According to the ...
Breaking Medicine News(10 mins):Health News:Minimally Invasive and Robotic Treatment for Pelvic Organ Prolapse Now Available from the Specialists at Women’s Excellence in Bladder Control 2Health News:New Patient Advocate Enhances Natural Health Care 2Health News:COMP-Northwest Welcomes Class of 2019 2Health News:COMP-Northwest Welcomes Class of 2019 3Health News:COMP-Northwest Welcomes Class of 2019 4Health News:COMP-Northwest Welcomes Class of 2019 5Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Local Retail Advocate Wins National Recognition 2
... , , Hospitals, Physicians ... , PRINCETON, N.J., Aug. 18 Twelve New Jersey ... government to test an innovative new incentive method that aims to ... The three-year trial program could serve as a basis ...
... Benefits for fighting norovirus include cost, speed, report shows ... developed a vaccine for the common viral infection norovirus ... new vaccine was "manufactured" in a tobacco plant using ... the door to faster, more inexpensive ways to bring ...
... , AUSTIN, Texas, Aug. 18 PetRel ... door-to-door pet trans p ortation services , has ... e tMD , to provide free pet travel and pet health ... will allow guests of PetMD to access PetRelocat i ...
... , ARLINGTON, Va., Aug. 18 ... Congress will add billions of dollars of un-reimbursed cost to ... patients," says K.C. McAlpin, executive director of ProEnglish, a national ... government in the United States. , , ...
... , , ... milestones achieved and immediate plans to move forward as a well ... the treatment of diabetes mellitus. Exsulin,s focus is on development of ... suffering from type 1 (T1DM) and type 2 diabetes (T2DM). ...
... , , JACKSONVILLE, Fla., ... network, today announced its partnership with Blue Cross and Blue ... and reduce the cost of care administration for Minnesotans. Blue ... the secure exchange of administrative health information between Minnesota physicians, ...
Cached Medicine News:Health News:Medicare Picks N.J. to Test Innovative Incentive System 2Health News:Medicare Picks N.J. to Test Innovative Incentive System 3Health News:Medicare Picks N.J. to Test Innovative Incentive System 4Health News:'Cruise Ship Virus' Vaccine Stems From Tobacco 2Health News:PetRelocation.com and PetMD.com Launch Co-Branded Pet Travel and Pet Health Resources 2Health News:PetRelocation.com and PetMD.com Launch Co-Branded Pet Travel and Pet Health Resources 3Health News:Exsulin Corporation Announces Publication of Phase 2 Trial Results for Novel Islet Regeneration Treatment in Type 1 & Type 2 Diabetes 2Health News:Exsulin Corporation Announces Publication of Phase 2 Trial Results for Novel Islet Regeneration Treatment in Type 1 & Type 2 Diabetes 3Health News:Exsulin Corporation Announces Publication of Phase 2 Trial Results for Novel Islet Regeneration Treatment in Type 1 & Type 2 Diabetes 4Health News:Availity Teams with Blue Cross and Blue Shield of Minnesota to Improve Health Care Efficiencies 2Health News:Availity Teams with Blue Cross and Blue Shield of Minnesota to Improve Health Care Efficiencies 3
(Date:7/31/2015)... , July 31, 2015 Egalet ... integrated specialty pharmaceutical company focused on developing, manufacturing ... closing of its previously announced underwritten public offering ... a public offering price of $11.25 per share. ... included 1,000,000 shares issued upon the exercise in ...
(Date:7/31/2015)... Calif. , July 31, 2015  Xencor, Inc. ... engineered monoclonal antibodies for the treatment of autoimmune diseases, ... appointment of Yujiro S. Hata to its ... experience in business and corporate development is a tremendous ... Ph.D., president and chief executive officer of Xencor. "Xencor ...
(Date:7/30/2015)... IRVINE, Calif. , July 30, 2015 Edwards ... the science of heart valves and hemodynamic monitoring, today announced ... company,s Board of Directors. "Bob is an ardent ... been a true privilege to have him on Edwards, board ... A. Mussallem , Edwards, chairman and CEO.  "Bob has provided ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3
... CO-Oximeter Control (Bayer 800 Series) is ... monitoring the performance of blood gas, ... 270 and 800 series) instrumentation. This ... Bayer 800 Rapidlab Series instruments in ...
Liquichek Blood Gas Plus CO-Oximeter Control (IL Synthesis Series) is a combination control for use in monitoring the performance of blood gas, ion-selective electrode, biosensor and CO-Oximetry anal...
Liquichek Blood Gas Plus E Control is an aqueous product used to monitor the measurement of pH, pCO2, pO2 and electrolytes. Available in four levels....
Liquichek CK/LD Isoenzyme Control features analytes used in cardiac profile testing and protein electrophoresis. Assayed for most methods including instruments, immunoinhibition kits and electrophore...
Medicine Products: